ZIMLAB
Zim Laboratories Limited
Pharmaceuticals · ₹609 Cr market cap
A pharmaceutical manufacturer established in 1989, Zim Laboratories specializes in producing formulation drugs and pre-formulation ingredients for both domestic and international markets. The company operates manufacturing facilities across India with capabilities in drug development, quality assurance, and distribution. It serves healthcare providers and patients through a diversified portfolio of therapeutic formulations marketed within India and exported to markets worldwide.
0
Tracked investors holding
1
Tracked moves
₹116
Share price
Latest activity
Mathew CyriacIncreased
Mathew Cyriac increased his stake in Zim Laboratories from 11.84% to 19.34%, acquiring 40,12,702 shares for ₹26.69 Cr at ₹66.51 apiece through an open market purchase. This transaction crossed the 5% disclosure threshold.
Track smart money in Zim Laboratories Limited
Get alerted when a top investor buys or sells.
Get started